SRPT: Sarepta Therapeutics Bozor kapitallashuvining daromadga nisbati

Sarepta Therapeutics Inc (SRPT) brendining ramzi va logotipi

Sarepta Therapeutics, Inc. (SRPT) gen terapiyalarini yetkazib berishda o'ta aniq kriologistikaga tayanadi va noyob patologiyalar nishasida ustunlik qilish uchun global sog'liqni saqlash gigantlari bilan shiddatli raqobat muhitida faoliyat yuritmoqda. Fundamental P/S koeffitsiyenti bozor evforiyasini o'z vaqtida aniqlash imkonini beradi, bunda ushbu ko'rsatkich hozirda 0.80 darajasida saqlanmoqda. Kompaniyaga tegishli monopoliya maqomi patentlar va FDA tasdig'i bilan ta'minlangan bo'lib, ular yangi ishtirokchilar uchun yengib bo'lmas kirish to'siqlarini yaratadi.

SRPT sarepta.com Narxning daromadga nisbati (04.07.2022 - 17.11.2026)

Sarepta Therapeutics Inc (SRPT) kompaniyasi koʻrsatkichlari kesimi va tahlili

- kotirovkalar va tahlilchilar prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning umumiy tahlili:SRPT - Sarepta Therapeutics Inc
Sarepta Therapeutics brend mahsuloti

P/S koeffitsiyenti biznesning bozor qiymatini uning generatsiya qilgan daromadlari bilan solishtiradi, bu esa sotuvlarning har bir dollari qiymatini baholash va aktivning haddan tashqari sotib olinganlik darajasini aniqlash imkonini beradi. Duchenne terapiyasi bo'yicha monopoliyaga ega bo'lgan Sarepta Therapeutics, Inc. (SRPT) uchun narx/sotuv koeffitsiyenti Elevidys platformasining kengayishiga nisbatan bozor kutganlarini aks ettiradi va patent ustunligi saqlanib turgan holda, mahalliy pasayishlarni fundamental past baholanganlik ko'rsatkichiga aylantiradi.

Sarepta Therapeutics, Inc. kimlar bilan raqobatlashadi

TEM (Tempus AI, Inc.) - Bozor kapitallashuvining daromadga nisbati|Qiagen Group - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IONS|RGEN - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Avidity Biosciences RNA|CRSP: P/S multiplikatori|Kapitalizatsiya va daromad nisbati WGS|RARE (Ultragenyx Pharma) - P/S multiplikatori|P/S multiplikatori Beam Therapeutics Inc.|Narxning daromadga nisbati Twist Bioscience, Inc. (TWST)|Kapitalizatsiyaning daromadga nisbati 10x Genomics TXG|Narxning daromadga nisbati Intellia Therapeutics NTLA|Kapitalizatsiyaning sotish hajmiga nisbati STOK (Stoke Therapeutics, Inc.)|BLFS - Narxning daromadga nisbati|Sotuvga nisbatan narx Wave Pharma|mazetx.com (MAZE) - Narxning daromadga nisbati|SION - Narx/daromad koeffitsiyenti|PRME (Prime Medicine Inc) - P/S multiplikatori|Taysha Gene Therapies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori QURE|MGTX: Narxning sotuvga nisbati|Narxning daromadga nisbati REGENXBIO RGNX|SLDB: Kapitalizatsiya va daromad nisbati|OCGN: Kapitalizatsiyaning daromadga nisbati|PACB - P/S multiplikatori|BNTC (Benitec Corp) - Kapitalizatsiyaning daromadga nisbati|Narx/daromad multiplikatori Design Corp DSGN|Narxning daromadga nisbati Rocket Pharmaceuticals|P/S multiplikatori 4D Molecular Therapeutics, Inc.|Narxning daromadga nisbati Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EDIT (Editas Medicine, Inc.)|P/S multiplikatori Silence Therapeutics Corp SLN|PRQR - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Codexis Inc CDXS|SGMO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati NAUT|Narxning daromadga nisbati metagenomi.co|P/S multiplikatori Precision BioSciences Inc.|P/S multiplikatori GBIO|Boundless Bio, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori XCUR (Exicure, Inc.)|Narx/daromad koeffitsiyenti Imunon, Inc. (IMNN)|PHIO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MBIO (mustangbio.com)|RNAZ: P/S multiplikatori|Kapitalizatsiya va daromad nisbati BNGO|APDN (Applied DNA Corp) - P/S multiplikatori|BLUE: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati ImmunoPrecise (IPA)|OMGA - Sotuvga nisbatan narx|Narxning daromadga nisbati Singular Genomics OMIC|Bozor kapitallashuvining daromadga nisbati RGLS|Syros Pharmaceuticals, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Telesis Bio Inc. TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Narxning daromadga nisbati|Unity Biotechnology, Inc - Bozor kapitallashuvining daromadga nisbati